Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available
In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal
President, First Lady Visit Clinical Center, Hail ‘Compassion’
ASCO Awards Contract For D.C. Office
Eight Scientists Receive $800,000 From Milken
Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB
U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
